Back to Agenda
Practical Approaches and Resources to Optimize Advocacy Group - Industry Collaborations: An Update on the PALADIN Consortium
Session Chair(s)
Victoria DiBiaso, BSN, MPH, RN
Global Head, Patient Informed Development and Health Value Translation
Sanofi, France
This session will discuss patient advocacy groups and pharmaceutical companies and the co-created the patient advocacy leaders and drug development industry network (PALADIN), a US focused pre-competitive and disease agnostic Consortium, to advance the pace of medicines development.
Learning Objective : Describe progress made by PALADIN (patient advocacy leaders and drug development industry network), a pre-competitive alliance of 20+ organizations formed in 2023; Discuss how the Consortium was established, it’s mission and governance; Identify year one resources created to optimize collaborations; Discuss priority year two activities and long-range plans.
Speaker(s)
Practical Approaches and Resources to Optimize Advocacy Group - Industry Collaborations: An Update on the PALADIN Consortium
Kenneth Getz, MBA
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Patient Perspective
Hollie Schmidt, MS
Accelerated Cure Project, United States
Vice President of Scientific Operations
Have an account?